United States Daily Briefing

US equities drifted into cautious consolidation Monday, per StockMarketWatch, as markets parked risk ahead of Nvidia Q2 2026 earnings. The tech sector complex — NVDA -1.3%, AMD -0.73%, AAPL -0.80% — gave back ground to Energy and Financials. CVX +2.6% and the Energy sector's +1.9% gain confirm that factor rotation has shifted away from growth-momentum. The factor call heading into Nvidia results: a miss on data-center revenue guidance (consensus calls for AI spending acceleration) triggers a sharp de-risking. A beat reverses today's selling with equal velocity. Current set-up favors hedged positioning rather than a clean directional bet.

The Form 4 data for the past 72 hours is the loudest institutional signal of the week. Warburg Pincus disclosed two tranches of SHC (Sotera Health) sales totaling $579.5M — 83% of all insider-sale volume. NBIS Chief Infrastructure Officer Andrey Korolenko added $101.6M. Total sales: $695.7M from 27 transactions vs. just 3 buys at $13.4M. The one counter-signal worth flagging: Robert Duggan's $13M PLSE (Pulse Biosciences) purchase. Duggan has a track record of high-conviction biotech plays (Pharmacyclics pre-AbbVie acquisition), so the PLSE stake is a longer-horizon speculative note — but the aggregate 52-to-1 sell/buy ratio screams distribution, not accumulation.

Delta CEO Ed Bastian confirmed Monday that Delta Air Lines will sit out US aviation consolidation and focus on international expansion through partnerships, per LiveMint reporting. Even as a transaction-friendly Trump regulatory posture lowers M&A barriers domestically, Bastian sees better unit economics in global routes. The trade implication: DAL is positioning for yield-driven international premium, not scale-driven domestic cost cuts. Watch Delta's Q2 international revenue mix as the thesis validator — and the divergence trade between international-tilt carriers (DAL, UAL) vs domestic-focused Southwest (LUV).